ATE332970T1 - Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums - Google Patents
Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstumsInfo
- Publication number
- ATE332970T1 ATE332970T1 AT99970398T AT99970398T ATE332970T1 AT E332970 T1 ATE332970 T1 AT E332970T1 AT 99970398 T AT99970398 T AT 99970398T AT 99970398 T AT99970398 T AT 99970398T AT E332970 T1 ATE332970 T1 AT E332970T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- compositions
- cell growth
- neoplastic cell
- inhibiting neoplastic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000009826 neoplastic cell growth Effects 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10408098P | 1998-10-13 | 1998-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332970T1 true ATE332970T1 (de) | 2006-08-15 |
Family
ID=22298575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04025897T ATE363536T1 (de) | 1998-10-13 | 1999-10-05 | Verfahren und zusammenstzung zur hemmung des wachtums von neoplastischen zellen |
| AT99970398T ATE332970T1 (de) | 1998-10-13 | 1999-10-05 | Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04025897T ATE363536T1 (de) | 1998-10-13 | 1999-10-05 | Verfahren und zusammenstzung zur hemmung des wachtums von neoplastischen zellen |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1121439B1 (de) |
| JP (1) | JP2002527452A (de) |
| KR (2) | KR100448427B1 (de) |
| AT (2) | ATE363536T1 (de) |
| AU (1) | AU758462B2 (de) |
| CA (1) | CA2344465A1 (de) |
| DE (2) | DE69932342T2 (de) |
| DK (2) | DK1121439T3 (de) |
| ES (2) | ES2290606T3 (de) |
| IL (3) | IL142088A0 (de) |
| MX (1) | MXPA01003636A (de) |
| NZ (1) | NZ510584A (de) |
| PT (2) | PT1121439E (de) |
| WO (1) | WO2000021996A2 (de) |
| ZA (1) | ZA200102380B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7169906B2 (en) | 1997-09-17 | 2007-01-30 | Genentech, Inc. | PRO211 polypeptides |
| US6974689B1 (en) | 1997-09-18 | 2005-12-13 | Genentech, Inc. | Nucleic acid encoding PRO211 polypeptides |
| AU4880901A (en) | 2000-04-21 | 2001-11-07 | Takeda Chemical Industries Ltd | Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| CA2710775A1 (en) * | 2007-12-28 | 2009-07-09 | Bioinvent International Ab | Formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ226799A (en) * | 1987-11-06 | 1991-08-27 | Oncogen | Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor |
| US5814307A (en) * | 1989-04-10 | 1998-09-29 | Bristol-Myers Squibb Company | Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6 |
| US5416192A (en) * | 1990-04-03 | 1995-05-16 | Bristol-Myers Squibb Company | Epithelins: novel cysteine-rich growth modulating proteins |
| AU9312198A (en) * | 1997-09-17 | 1999-04-05 | Genentech Inc. | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer |
| KR100502596B1 (ko) * | 1997-09-17 | 2005-07-22 | 제넨테크, 인크. | 분비 폴리펩티드와 막횡단 폴리펩티드 및 이들을 코딩하는핵산 |
-
1999
- 1999-10-05 MX MXPA01003636A patent/MXPA01003636A/es active IP Right Grant
- 1999-10-05 DK DK99970398T patent/DK1121439T3/da active
- 1999-10-05 ES ES04025897T patent/ES2290606T3/es not_active Expired - Lifetime
- 1999-10-05 ES ES99970398T patent/ES2268901T3/es not_active Expired - Lifetime
- 1999-10-05 EP EP99970398A patent/EP1121439B1/de not_active Expired - Lifetime
- 1999-10-05 PT PT99970398T patent/PT1121439E/pt unknown
- 1999-10-05 AT AT04025897T patent/ATE363536T1/de active
- 1999-10-05 AT AT99970398T patent/ATE332970T1/de active
- 1999-10-05 JP JP2000575898A patent/JP2002527452A/ja active Pending
- 1999-10-05 DK DK04025897T patent/DK1518930T3/da active
- 1999-10-05 CA CA002344465A patent/CA2344465A1/en not_active Abandoned
- 1999-10-05 KR KR10-2003-7014739A patent/KR100448427B1/ko not_active Expired - Fee Related
- 1999-10-05 DE DE69932342T patent/DE69932342T2/de not_active Expired - Lifetime
- 1999-10-05 ZA ZA200102380A patent/ZA200102380B/en unknown
- 1999-10-05 PT PT04025897T patent/PT1518930E/pt unknown
- 1999-10-05 DE DE69936234T patent/DE69936234T2/de not_active Expired - Lifetime
- 1999-10-05 IL IL14208899A patent/IL142088A0/xx active IP Right Grant
- 1999-10-05 WO PCT/US1999/023089 patent/WO2000021996A2/en active Application Filing
- 1999-10-05 AU AU12005/00A patent/AU758462B2/en not_active Expired
- 1999-10-05 NZ NZ510584A patent/NZ510584A/xx not_active IP Right Cessation
- 1999-10-05 KR KR10-2001-7004627A patent/KR100448426B1/ko not_active Expired - Fee Related
-
2001
- 2001-03-19 IL IL142088A patent/IL142088A/en not_active IP Right Cessation
-
2008
- 2008-02-13 IL IL189502A patent/IL189502A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ510584A (en) | 2003-04-29 |
| JP2002527452A (ja) | 2002-08-27 |
| DK1121439T3 (da) | 2006-11-13 |
| CA2344465A1 (en) | 2000-04-20 |
| WO2000021996A3 (en) | 2000-11-09 |
| EP1121439A2 (de) | 2001-08-08 |
| WO2000021996A2 (en) | 2000-04-20 |
| IL189502A0 (en) | 2008-06-05 |
| ATE363536T1 (de) | 2007-06-15 |
| EP1121439B1 (de) | 2006-07-12 |
| ES2268901T3 (es) | 2007-03-16 |
| PT1121439E (pt) | 2006-12-29 |
| MXPA01003636A (es) | 2003-10-14 |
| IL142088A0 (en) | 2002-03-10 |
| KR20010085915A (ko) | 2001-09-07 |
| AU1200500A (en) | 2000-05-01 |
| AU758462B2 (en) | 2003-03-20 |
| KR100448426B1 (ko) | 2004-09-13 |
| DE69932342D1 (de) | 2006-08-24 |
| PT1518930E (pt) | 2007-09-04 |
| DE69936234T2 (de) | 2008-03-06 |
| KR20030096387A (ko) | 2003-12-24 |
| DK1518930T3 (da) | 2007-10-01 |
| DE69936234D1 (de) | 2007-07-12 |
| DE69932342T2 (de) | 2007-07-12 |
| ES2290606T3 (es) | 2008-02-16 |
| IL142088A (en) | 2008-11-26 |
| ZA200102380B (en) | 2002-03-22 |
| KR100448427B1 (ko) | 2004-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69918089D1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| WO2003103581A3 (en) | COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION | |
| DE602004015811D1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
| DE69936890D1 (de) | Vorrichtung zur Behandlung von Ischämie | |
| ATE294595T1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| DE60015070D1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| WO2001075178A3 (en) | Methods for identifying peptide aptamers capable of altering a cell phenotype | |
| ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| IS5856A (is) | Aðferðir þar sem integrín-mótlyf eru notuð til aðmeðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla | |
| DE69941821D1 (de) | Fluorenthaltende zusammensetzung zur behandlung von oberflächen | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| ATE196083T1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| ATE287734T1 (de) | Radionukleiide assoziierte nukleotid- polyphosphate zur bilddarstellung von tumoren | |
| IL189502A0 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
| MX9605072A (es) | Dispositivo dispensador para pretratamiento. | |
| DE69832363D1 (de) | Betulinsauer Derivate zur Hemmung von Krebswachstum | |
| DE60137721D1 (de) | Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs | |
| DE69915690D1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| IL158433A (en) | Toluene sulfonamide-containing anti-tumor composition and method of use thereof | |
| MXPA05001690A (es) | Estrategia de deteccion para farmacos anticancer. | |
| ATE288498T1 (de) | Methoden zur inhibierung von helicobacter pylori | |
| WO2000012754A8 (en) | Method for identifying substances for the treatment of c-jun-mediated disorders | |
| DE60312988D1 (de) | Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea | |
| EP1518930A3 (de) | Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1121439 Country of ref document: EP |